New

Woking, UK, 31 March 2022 - TT Electronics, a global provider of engineered technologies for performance critical applications, today announced the receipt of U.S. Federal Drug Administration (FDA) registration for its Minneapolis, Minnesota manufacturing facility. Securing this registration allows the company to manufacture finished instruments and devices such as imaging, diagnostic and therapeutic equipment for the healthcare market, in the USA.

Now as an FDA registered location, the facility is recognised by and subject to the rigorous standards of the FDA, further reinforcing the company’s commitment to supporting its global customers with a wide range of high-reliability products and services across key highly regulated end markets. This development also builds on FDA registration received last year by the TT Cleveland facility which has paved the way for increasing collaboration between the two locations to further support our medical customers with complete, vertically integrated solutions by utilising the complimentary capabilities of our teams and sites in Ohio and Minnesota respectively. These registrations and this enhanced value offering further demonstrates the steps TT is actively taking to better respond to the increased demand seen in the medical and life science domain.

“This latest milestone demonstrates our commitment to the healthcare industry and the momentum behind our growth strategy. FDA designation is not easily awarded and will provide a significant advantage in supporting our current customer base, many of whom are global leaders in their fields. TT has long been a partner for medical device and life science technology innovators and we’re proud to continue securing milestones like this one to support our customers with an enhanced ability to leverage our growing capabilities in the USA. Our increasing expertise and track record in manufacturing and delivering finished, complex medical products – still founded on world-class service is a compelling offering which we’re delighted to provide to our partners.” said TT Electronics Power Solutions VP/GM, Matt Sweaney.

Manufacturing facilities involved in the production and distribution of medical devices intended for use in the United States healthcare sector are required to register annually with the FDA. This registration provides the FDA with the location of medical device establishments and the devices manufactured at those establishments. Knowing where devices are made increases the nation’s ability to prepare for and respond to public health emergencies such as those experienced in recent years in responding to the coronavirus pandemic.

About TT Electronics plc

TT Electronics is a global provider of engineered technologies for performance critical applications.

TT solves technology challenges for a sustainable world. TT benefits from enduring megatrends in structurally high-growth markets including healthcare, aerospace, defence, electrification and automation. TT invests in R&D to create designed-in products where reliability is mission critical. Products designed and manufactured include sensors, power management and connectivity solutions. TT has design and manufacturing facilities in the UK, North America, Sweden and Asia.

For more information about TT Electronics, visit www.ttelectronics.com.